Objective-We sought to identify novel atherosclerosis-modifying loci and their potential functional links in a genome-wide approach using cosegregation analysis of atherosclerosis and related intermediate phenotypes in mice. Methods and Results-We carried out an F2 intercross between atherosclerosis-susceptible C57BL/6 mice and atherosclerosis-resistant BALB/cByJ mice on the low-density lipoprotein receptor Ϫ/Ϫ background to examine the genetic basis for their differences in atherosclerosis susceptibility. Atherosclerotic lesion size and a comprehensive panel of 61 atherosclerosis-related phenotypes, including plasma levels of lipids, cytokines, and chemokines were measured in 376 F2 mice. Quantitative trait locus mapping revealed a novel significant locus (logarithm of odds, 6.18) for atherosclerosis on proximal mouse chromosome (Chr) 2 (Ath39), which was associated with major variations in lesion size (14%). Plasma very-low-density lipoprotein-cholesterol, high-density lipoprotein-cholesterol, lanosterol, and phytosterol levels cosegregated with atherosclerosis at this locus. Moreover, these lipid traits showed significant correlations with lesion size, suggesting that they share the same underlying genetic factor. We also describe a second male-specific locus on Chr 8 (Ath40) where atherosclerosis and lipids cosegregated. Conclusion-Our study revealed new loci for atherosclerosis susceptibility on mouse Chr 2 and 8, which might exert their effects on lesion size via plasma lipid levels. (Arterioscler Thromb Vasc Biol. 2011;31:775-784.)
D espite successes in treatment of risk factors, atherosclerotic cardiovascular disease remains the major cause of morbidity and mortality in much of the world today. 1 Susceptibility to atherosclerosis is a complex genetic trait, determined by multiple genetic and environmental factors. Heritability estimates demonstrated that up to 50% of the disease susceptibility is attributable to genetics, 2 making genetic factors a major contributor to pathogenesis. Recently, genome-wide association studies in humans have led to the identification of several novel loci of atherosclerotic cardiovascular disease. 3 Genetic differences in susceptibility to atherosclerosis have also been described between several inbred mouse strains 4 -6 and used in unbiased genome-wide linkage studies to map genomic regions and atherosclerosismodulating genes. More than 30 quantitative trait loci (QTLs) for atherosclerosis have been identified by linkage mapping in mice, many of which exhibit corresponding loci in homologous regions in humans. 7 Because it is likely that the same orthologous genes are responsible for concordant loci in mice and humans, identifying atherosclerosis genes in mice can provide important new insights relevant to human pathology. This can be exemplified by the identification of Alox5 (mice)/ALOX5AP (human) and Tnfsf4 (ox40L) as new atherosclerosis-modulating genes in mice and humans. 8 -10 The fact that most recent mouse linkage studies were able to identify new genomic regions for atherosclerosis suggests that our current inventory of QTLs is still incomplete and that crosses with different mouse strains might yield novel biological insights. C57BL/6 mice are widely used as an atherosclerosis-sensitive strain, whereas the distantly related BALB/cByJ strain was described to be atherosclerosis resistant when fed a high-cholesterol diet, supplemented with cholic acid or on the apolipoprotein E-deficient background. 5, 11 Notably, both strains also exhibit opposite T-cell polarization with regard to Th1 and Th2 response. 12, 13 This might add to their difference in atherosclerosis susceptibility because the immune system and inflammatory responses are important contributors to atherogenesis. 14 In the present study, we performed an intercross between C57BL/6 and BALB/cByJ mice on the low-density lipoprotein receptor (LDLR) Ϫ/Ϫ background to examine the genetic bases for the differences in atherosclerosis susceptibility between these strains. We determined atherosclerotic lesion size and a comprehensive panel of 61 additional phenotypes, including plasma cytokines and metabolic parameters of sterol and lipoprotein metabolism, in the entire F2 generation. QTL mapping was performed for all 62 phenotypes, and we specifically investigated cosegregation between loci for atherosclerotic lesion size and atherosclerosis-modifying factors, hypothesizing that they share the same causal variant.
Methods
Mice LDLR-deficient mice on the C57BL/6 background (B6.129S7-Ldlr tm1Her /J, henceforth called B6.LDLR Ϫ/Ϫ ) and BALB/cByJ mice were obtained from the Jackson Laboratory. LDLR Ϫ/Ϫ mice on the BALB/cByJ background (henceforth called BALB.LDLR Ϫ/Ϫ ) were generated in our laboratory by marker-assisted backcrossing. F1 and F2 animals were generated in 2 ways. In cross mBALBϫfB6, male BALB.LDLR Ϫ/Ϫ mice were crossed to female B6.LDLR Ϫ/Ϫ mice, and the resulting F1s were intercrossed to generate 95 male and 95 female F2s. In cross mB6ϫfBALB, male B6.LDLR Ϫ/Ϫ mice were crossed to female BALB.LDLR Ϫ/Ϫ mice, and the F1s were intercrossed to generate 94 male and 92 female F2s. All mice were weaned at 28 days of age and fed a semisynthetic modified AIN76 diet containing 0.02% cholesterol for 16 weeks until euthanization. 6 The sterol content of that diet is described in Supplemental Table I , available online at http://atvb.ahajournals.org. On the day of euthanization, food was removed from the cage, and mice were allowed access to water. Mice were anesthetized and exsanguinated by left-ventricular puncture into EDTA-containing syringes. The circulation was flushed with PBS, and the heart and brachiocephalic artery were removed and snap-frozen in Tissue-Tek OCT compound. 6 Omental, perirenal, and parametral/epidydimal fat pads, as well as liver and kidneys, were collected. Animals were housed in a specific pathogen-free environment, and all procedures involving mice were approved by the Regierungspräsidium Leipzig (N5/05, N6/06).
Blood Analyses
Clinical chemistry parameters were measured on automated analyzers (Modular PPE, Roche). Plasma lipoproteins were isolated by sequential ultracentrifugation at density Ͻ1.006 g/mL (very-lowdensity lipoprotein [VLDL]), 1.006ՅdՅ1.063 g/mL (intermediate density lipoprotein, low-density lipoprotein [LDL]), and d Ͼ1.063 g/mL (high-density lipoprotein [HDL]) as described. 15 Phytosterols were measured by tandem mass spectrometry (atmospheric pressure photoionization [APPI] liquid chromatography-tandem mass spectrometry [LC-MS/MS]; API 3000) as described. 16 Plasma cytokine levels were determined by multiplex cytokine immunoassays (Lincoplex) on a Bioplex Protein Array System analyzer (Bio-Rad) following the recommendations of the manufacturer.
Quantification of Atherosclerosis
To quantify cross-sectional lesion area in the aortic root, hearts frozen in OCT were processed and stained as previously described. 6
Genome Scan
Genomic DNA was isolated from mouse tail tips. Genotyping was performed using a set of microsatellite markers previously screened to be polymorphic between B6 and BALB. Forward primers were fluorescently labeled with the dyes 6-carboxyfluorescein, 4,7,2Ј,4Ј,5Ј,7Ј-hexachloro-6-carboxyfluorescein, and 2,7Ј,8Ј-benzo-5Ј-fluoro-2Ј,4,7-trichloro-5-carboxyfluorescein. The reverse primers were unlabeled, but a GCTTCT sequence was attached to the 5Ј end to reduce stutter bands. The markers were grouped into 13 panels of 8 to 10 markers each. The initial genome scan was done with 107 markers spaced at Ϸ15-cM intervals. Single-nucleotide polymorphisms used for fine mapping were obtained from databases (http:// www.informatics.jax.org/) and experimentally verified by DNA sequencing. The 12 single-nucleotide polymorphisms for fine mapping were analyzed by melting curve analysis using a homogenous fluorescent method. 17 All marker names, fluorescent labels, and paneling information are listed in Supplemental Table II . Genotyping was performed at the Genomics Resource Center of the Rockefeller University as previously described. 15 
RNA Isolation and Quantitative Reverse Transcription-Polymerase Chain Reaction
Total RNA was extracted from livers of 376 F2 mice using Trizol reagent and reverse transcribed into cDNA using SuperScript II Reverse Transcriptase (Invitrogen) and random hexamer primers. Quantitative fluorogenic reverse transcription-polymerase chain reaction was performed in an ABI Prism 7900 Sequence Detection System (Applied Biosystems). Specific primers and probes for Pla2r1 and Nr4a2 were selected to span 2 exons to avoid coamplification of genomic DNA. mRNA expression levels were normalized to 10 6 copies of ␤-actin as a housekeeping gene. Polymerase chain reaction conditions and primer and probe sequences for Pla2r1, Nr4a2, and ␤-actin are provided in Supplemental Table III .
Statistical Analysis and Bioinformatics
All data are expressed as meanϮstandard deviation unless otherwise indicated. Normality of distribution was assessed using the Kolmogorov-Smirnov test implemented in the Prism statistical software (GraphPad). Comparison of multiple groups was done using the Kruskal-Wallis test and the Dunn multiple comparison test as a post test, and comparison of 2 groups was done using the Mann-Whitney test. For linkage analysis, atherosclerotic lesion measurements were square root transformed to achieve normality. All other phenotypic traits significantly deviating from normal distributions were either log or square root transformed to achieve normality. Linkage analysis for single QTL was performed using MapManager QTX, version b20. 18 Logarithm of odds (LOD) scores were calculated using the free model in MapManager QTX, and levels of significance for LOD scores were determined empirically by permutation testing (nϭ1000) in 1-cM steps. Information on syntenic regions between mice and humans was obtained from the Ensembl database (http://www.ensembl.org), and haplotype information was extracted using the Mouse Haplotype Block viewer (http://mouse.perlegen.com/mouse/mousehap.html). Information on genes mapping to mouse chromosome (Chr) 2 was accessed at Jax Mouse Genome Informatics (http://www.informatics.jax.org/). The Mouse Map Converter Tool (http://cgd.jax.org/mousemapconverter/) was applied to calculate physical positions from genetic map positions.
Results
Phenotyping of Parental B6.LDLR ؊/؊ and BALB.LDLR ؊/؊ F0 Mice BALB.LDLR Ϫ/Ϫ and B6.LDLR Ϫ/Ϫ mice were euthanized after 16 weeks on a standardized semisynthetic diet and extensively phenotyped. Atherosclerotic lesion size at the aortic root and 61 additional traits, including anthropometric parameters, a comprehensive panel of metabolic parameters (including plasma concentrations of lipids, lipoproteins and sterol metabolites), and plasma concentrations of 20 cytokines and chemokines (Table) , were determined. BALB.LDLR Ϫ/Ϫ mice showed a marked resistance to atherosclerosis and developed significantly smaller lesions than B6.LDLR Ϫ/Ϫ mice (Supplemental Figure IA and IB), which is in accordance with results in B6 and BALB strains from diet-induced atherosclerosis studies. 5 Interestingly, both strains showed differences in their lipid profiles, whereas strain effects on plasma cytokines and chemokines were negligible (Table) . Because we observed significant sex differences for several traits, including lesion size ( Supplemental Table IV ), male and female mice were subsequently analyzed separately.
Genetic Determinants of Atherosclerosis in BALB.LDLR ؊/؊ and B6.LDLR ؊/؊ Mice
To identify genetic loci responsible for differences in atherosclerosis susceptibility, we generated 376 F2 mice by intercrossing BALB.LDLR Ϫ/Ϫ and B6.LDLR Ϫ/Ϫ mice and performed QTL mapping. Atherosclerotic lesion size at the aortic root in F2 mice showed a wide range of variation (Supplemental Figure IA and IB). As a major finding, we identified a novel QTL for atherosclerotic lesion size at the aortic root (Ath39) on proximal Chr 2 ( Figure 1 ). This locus was present in male mice (LOD 6.18, empirical probability value Ͻ0.001, Figure 1A ) and female mice (LOD 6.20, empirical probability value Ͻ0.001, Figure 1B) , with similar fits in the additive and dominant models. The locus was associated with 14% of the variation in atherosclerotic lesion size in both sexes. For fine mapping, 3 additional single-nucleotide polymorphism markers were added to this locus. As shown in the interval maps in Figure 1 , we observed the highest LOD score near D2Mit7 (28.0 cM, 38.1 Mb) in male mice ( Figure  1A ). In female mice ( Figure 1B) , the LOD score plot showed bimodal LOD peaks with a maximum near marker rs27192030 (34.4 Mb) . We next analyzed the allelic contributions at this locus and found that the B6 allele was the risk allele conferring atherosclerosis susceptibility ( Figure 1C and 1D ).
To account for lineage effects on atherosclerosis susceptibility revealed in our previous work, 15 the current cross had been set up in a reciprocal fashion. To this end, 190 F2s had been generated by crossing male B6.LDLR Ϫ/Ϫ mice to female BALB.LDLR Ϫ/Ϫ mice and crossing the resulting F1s (cross mB6ϫfBALB). The remaining 186 F2s had been generated by crossing male BALB.LDLR Ϫ/Ϫ mice with female B6.LDLR Ϫ/Ϫ mice and crossing the resulting F1s (cross mBALBϫfB6). However, lineage effects did not seem to exhibit a major influence on lesion size in this intercross, as the QTL on Chr 2 was supported in both subcrosses ( Figure 1A and 1B) with similar genotypic effects ( Figure 1C and 1D), and no differences in lesion size were observed between the 2 F2 subcrosses in males or females (Supplemental Figure IC ).
QTL Mapping for Genetic Determinants of Metabolic and Inflammatory Traits
We subsequently performed QTL mapping on 61 additional phenotypes, the majority representing traits related to atherosclerosis, to identify genetic loci contributing to these traits and investigate potential cosegregation patterns ( Figure 2 ). Such colocalizations of QTLs for different traits would suggest the possibility that the same gene within the region affects multiple traits, which could provide hints to common pathophysiological pathways and facilitate identification of the causal gene. In our study, genetic factors leading to differences in plasma lipid levels strongly colocalized with lesion development, whereas the genetic contribution of immunologic factors was less apparent, and no significant genetic loci for plasma cytokine concentrations were identified ( Figure 2 ). The latter observation was surprising because B6 and BALB mice have been recognized as Th1-and Th2-type immune response strains, respectively. 12, 13 
Cosegregation of Atherosclerosis and Lipid Traits at Chr 2
Notably, we identified cosegregation for traits related to lipid and sterol metabolism with the novel atherosclerosis locus on Chr 2 (Figure 2 ). The pattern was more pronounced in males (Figure 2A) , in which we observed highly significant QTLs for the phytosterol brassicasterol (LOD 5.7, PϽ0.001) and the cholesterol precursor lanosterol (LOD 5.3, PϽ0.001) peaking between D2Mit7 (38.1 Mb) and rs13476554 (67.1 Mb) ( Figure 3A) . The same genomic location also harbored significant QTLs for plasma VLDL-cholesterol (VLDL-C) (LOD 3.64, Pϭ0.03) and high-density lipoprotein cholesterol (HDL-C) (LOD 3.56, Pϭ0.036) ( Figure 3A) . Analysis of the allelic contributions showed that the B6 allele, in addition to conferring increased lesion size, was also conferring a less favorable lipid profile. The B6 allele increased plasma brassicasterol ( Figure 3B ), lanosterol ( Figure 3C ), and VLDL-C ( Figure 3D ) and decreased plasma HDL-C ( Figure  3E) . No effect was observed for plasma LDL-C ( Figure 3F ).
Identification of a Novel Sterol QTL at Chr 8
In addition to the Chr 2 locus, we identified a second novel QTL cluster on Chr 8 for plasma plant sterols colocalizing with a suggestive QTL for atherosclerotic lesion size (Ath40). These QTLs were sex specific and were present only in male mice (Figures 2A and 4A) . The Chr 8 QTL for plasma concentrations of the phytosterols brassicasterol (LOD 5.29, PϽ0.001), sitosterol (LOD 5.86, PϽ0.001), and campesterol (LOD 3.86, Pϭ0.023) peaked near D8Mit65, where we also mapped suggestive loci for atherosclerotic lesion size (LOD 3.28, Pϭ0.09) and LDL-C (LOD 2.95, Pϭ0.16) ( Figure 4A ). The B6 allele displayed an additive effect, increasing atherosclerotic lesion size ( Figure 4B ), plasma levels of phytosterols ( Figure 4C to 4E), and LDL-C ( Figure 4F) . In contrast to the Chr 2 locus, no significant linkage was observed for VLDL-C and HDL-C ( Figure 4A ). Because normalization of phytosterol traits to plasma cholesterol levels significantly decreased effects ( Figure  2A) , it is possible that the parallel increase of phytosterols and lipoprotein cholesterol was due to the binding of phytosterols to lipoproteins.
Correlation of Plasma Lipids With Atherosclerosis in F2
At the Chr 2 and Chr 8 loci, the B6 allele represented the risk allele, and the mode of inheritance was similar for plasma sterols, lipoprotein levels, and atherosclerotic lesions, raising the possibility that genetic factors contributing to lesion development in this cross were acting through plasma lipids, particularly in males. We therefore calculated correlations of these traits with atherosclerosis lesion size in the F2 ( Figure 5) . Overall, the strongest correlation with lesion size was observed for LDL-C (r 2 ϭ0.24, Figure 5A ), followed by brassicasterol (r 2 ϭ0.15, Figure 5B ), VLDL-C (r 2 ϭ0.11, Figure 5C ), and lanosterol (r 2 ϭ0.05, Figure 5D ). The correlation with HDL-C was weak and showed an inverse effect (r 2 ϭ0.04, Figure 5E ). Normalizing brassicasterol to cholesterol abolished the correlation with lesion size (Figure 5F ), suggesting that higher plasma plant sterols might be indicative of higher LDL-C and VLDL-C and reflect a higher concentration of plant sterols traveling with these lipo- proteins. This hypothesis was further supported by the highly significant correlations between brassicasterol and LDL-C (r 2 ϭ0.41, Supplemental Figure IIA) and between brassicasterol and VLDL-C (r 2 ϭ0.14, Supplemental Figure IIB) .
Potential Candidate Genes at Chr 2
At the novel QTL on Chr 2, atherosclerotic lesion size colocalized with plasma levels of plant sterols, lanosterol, VLDL-C, and HDL-C. The 95% support interval (defined by Table V) , 61 of which were only predicted genes. Among the remaining 158 annotated genes, 27 genes encoded olfactory receptors, and we did not consider these likely candidates. We then attempted to reduce the remaining list of 131 candidate genes by applying several strategies. First, we sought to identify regions within this locus that were nonidentical by descent (non-IBD) between the B6 and BALB parental strains, because such regions have a higher probability to contain the causal gene. However, an analysis of the ancestral haplotypes at this locus suggested that it was entirely IBD ( Figure 1A and 1B) between the B6 and BALB strains. Thus, incorporating information on ancestral haplotypes did not allow further reduction of the interval. Comparative genomics has been applied as an additive approach to reduce the size of QTL intervals and identify potential candidate genes. 19 This approach assumes that the same culprit gene is causal for a QTL in mice and humans if QTL exist at syntenic chromosomal regions. Indeed, several linkage studies in humans mapped atherosclerosis QTLs to Chr 2q22.1 (confidence interval, 2q21.2 to 24.3), 20 -22 which was reported to correspond to mouse Chr 2 between 30 and 38 cM. 23 Using Mouse Map Converter, 24 we transformed the genetic coordinates for this region to physical coordinates, resulting in a Ϸ12.3-Mb candidate region (52.30 to 64.60 Mb). The remaining candidate region harbored 63 genes, 19 of which were predicted genes. Thus, applying comparative genetics might allow reduction to 44 candidate genes at this locus ( Supplemental Table V) . Two notable candidate genes identified by their potential role in the pathophysiology of atherosclerosis were located in this region: Pla2r1, encoding a receptor for secretory phospholipase A2 and Nr4a2, encoding the orphan nuclear receptor NURR1. Several studies in mice and humans have linked NURR1 and secretory phospholipase A2, the ligand of PLA2R1, to lipoprotein metabolism, lipolysis, foam cell formation, and development of atherosclerosis. [25] [26] [27] [28] We investigated liver expression of both genes and performed expression QTL mapping in F2 mice to test whether we could detect significant differences in transcript levels based on allele status. Both genes were expressed in liver, but we did not detect significant expression differences or expression QTLs in F2 mice (Supplemental Figure  III) . Therefore, variants influencing liver expression of 
Discussion
In the current study, we used an intercross between B6 and BALB mouse strains on the LDLR Ϫ/Ϫ background to identify genomic regions that harbor QTLs for atherosclerosis. We identified a novel, strong locus for atherosclerotic lesion size at the aortic root on proximal Chr 2 (Ath39). To investigate potential mechanisms modulating atherosclerosis in this cross, we also determined a comprehensive panel of metabolic and system-related traits, including plasma levels of 20 cytokines and chemokines, and performed QTL mapping for these parameters. At Chr 2, lesion size colocalized with loci for plasma VLDL-C, HDL-C, the cholesterol biosynthesis marker lanosterol and the plant sterol brassicasterol. In male mice, a second QTL cluster for plasma plant sterol concentrations was identified on Chr 8, where we also mapped a suggestive QTL for atherosclerotic lesion size (Ath40) and LDL-C. Moreover, plasma lipid and sterol concentrations were significantly correlated with lesion size, raising the possibility that genetic factors contributing to lesion development in this cross were acting through plasma lipids. Although our study is the first to map a QTL for lesion size to proximal Chr 2, previous studies had mapped QTLs for plasma lipids and metabolic traits to proximal Chr 2: HDL1, a locus for plasma HDL-C near D2Mit9 (65.2 Mb), was first reported in a cross of CAST/Ei and C57BL/6J 29 and later confirmed in a cross of CAST and DBA mice. 30 Furthermore, Mob7, a locus for subcutaneous-/retroperitoneal-fat was also mapped to D2Mit9 (using CAST/Ei and C57BL/6 strains), 31 and more recently, loci for body weight, fat mass, and adipocyte size overlapping with Mob7 were identified in an independent model. 32 Interestingly, besides significant linkage for atherosclerosis and plasma sterols, we also observed suggestive linkage for fat mass in our study ( Figure 2) .
With regard to plasma plant sterol concentrations, Sehayek et al 33 mapped Plast2a near D2Mit296 (31.18 Mb) in a cross between Casa and C57BL/6J strains. Identically to our study, inheritance of the B6 allele increased plant sterol levels. Elevated concentrations of plasma plant sterols have been discussed as a potential risk factor for coronary artery disease in mice and humans. 34 This view was supported by a recent mendelian randomization study in humans, which revealed that loci for plant sterols identified by genome-wide association showed concordant associations with coronary artery disease. 35 In the present study, we also observed colocalization between brassicasterol and lesion size and significant correlations between these traits. Even though plasma concentrations of plant sterols are substantially lower than for cholesterol, a mechanistic link cannot be excluded. Deposits of plant sterols have been found in atherosclerotic lesions, 36 and patients with sitosterolemia, a rare autosomal disease caused by mutations in ABCG5/8, display severe accumulation of phytosterols and subsequently develop atherosclerosis. 37 On the functional level, it has been shown that sitosterol-containing lipoproteins trigger free sterol-induced caspase-independent death in acyl-CoA:cholesterol acyltransferase competent macrophages and might thus promote atherosclerosis. 38 However, VLDL-C and HDL-C also mapped to the same region on Chr 2, making it difficult to separate a putative effect of high plant sterol levels from other lipid risk factors. Moreover, normalizing plant sterol levels to plasma cholesterol abolished the linkage signal. Therefore, we hypothesize that plant sterols might instead be indicative of higher VLDL-C and reflect a higher concentration of plant sterols traveling on VLDL-C. One might also speculate that a common genetic modulator influences both traits by affecting sterol absorption in intestinal cells or hepatic excretion of sterols into bile.
Although we found the best correlation between LDL-C and lesion size, LDL-C did not map to the strongest locus for lesion size at Chr 2. However, a robust correlation and colocalization with lesion size at Chr 2 was observed for VLDL-C. It is also possible that the Chr 2 locus is complex and harbors closely linked but separate genes affecting plasma lipids and atherosclerosis. Cosegregation of plasma plant sterols, lipids, and atherosclerotic lesion size was also observed in a second novel, male-specific QTL on Chr 8. The associated interval contains 370 genes, 74 of which are only predicted genes ( Supplemental Table VI ). Interestingly, a haplotype block containing 3 genes (NCAN, CILP2, and PBX4) residing at the Chr 8 QTL interval was recently discovered in a genome-wide association study to be associated with total cholesterol, LDL-C, triglycerides, and risk for myocardial infarction in humans. 39 The culprit gene and its links to lipid metabolism and myocardial infarction remain unknown; however, the evidence from human studies makes these 3 genes priority candidates for future investigations aimed at elucidating the causal gene at this locus.
In addition to lipids, the immune system is widely recognized to influence atherogenesis, and a proatherogenic role has been postulated for most Th1 cytokines. 14 B6 mice exhibit a predominant Th1-immune response, whereas BALB mice exhibit a predominant Th2-immune response, 12, 13 implying that opposite T-cell polarization might convey some of the genetic difference in atherosclerosis susceptibility between these strains. It was therefore surprising that we could not detect significant QTLs for plasma concentrations of 20 cytokines and chemokines. Because plasma cytokine concentrations might not accurately reflect the local milieu of cytokines in the arterial wall, one cannot exclude a significant contribution of genetically programmed differences in Th1/ Th2 response on atherosclerotic lesion formation and quality in these strains. Also, in our study, plasma concentrations for many prototypic Th1/Th2 cytokines were comparable in the parental strains (Table) . Contrary to our observations, Schulte et al 11 reported significant differences in interleukin-6 plasma levels between BALB and B6 mice on the apolipoprotein E-deficient background. It is conceivable that the lack of replication of this finding in our study is due to a different atherosclerosis sensitizing mutation (apolipoprotein E) or a diet with significantly higher fat (40% kcal) and cholesterol (1.25%) content in the study of Schulte et al, 11 resulting in larger atherosclerotic lesions and a higher inflammatory burden.
Despite several lines of evidence pointing to proximal Chr 2 as a locus carrying a gene involved in lipid metabolism, body fat regulation, and now atherosclerosis, the underlying gene or genes at this locus have yet to be identified. Bioinformatics based strategies to narrow QTL intervals and identify the culprit variant include the use of ancestral haplotypes and comparative genomics approaches. Comparative genomics is based on the assumption that the same genes underlie QTL in syntenic regions of different species. The syntenic region in humans for parts of the mouse Chr 2 QTL support interval maps to Chr 2q22.1 to 2q32.1, a region where several linkage studies in humans mapped QTL for coronary heart disease and HDL-C. 20 -22 Based on a literature search for genes mapping to the syntenic regions, we prioritized 2 candidate genes with links to lipid metabolism and atherosclerosis for functional studies. We determined liver mRNA expression of Nurr1 and Pla2r1 in F2 mice, but we did not detect expression differences based on allele status at D2Mit7. However, this finding does not completely rule out the possibility that expression differences of either of the genes are responsible for the atherosclerosis QTL at this locus because other tissues might show an expression QTL mapping. 40 A limitation of the present study was that we were unable to further reduce the QTL interval by applying a haplotype block analysis, because it was mainly IBD, indicative of a high level of conservation between the 2 strains. This finding represents an interesting case for a QTL region, because IBD regions are commonly excluded in bioinformatics approaches used to narrow QTL intervals under the assumption that shared ancestral regions are unlikely to contain the culprit variant. The causal mutation underlying the QTL in our study has most likely arisen as a de novo mutation after the separation of strains. Nextgeneration sequencing technology now enables efficient sequencing of large genomic regions, and the Chr 2 interval might be a case in point for the use of next-generation sequencing to unravel the causative mutation(s) in the gene(s) modulating plasma sterols and atherosclerosis.
In summary, cosegregation analysis identified new QTLs for atherosclerotic lesion size, lanosterol, VLDL-C, HDL-C and brassicasterol on proximal Chr 2 by intercrossing B6 and BALB mice on the LDLR Ϫ/Ϫ background. Our data are supported by linkage studies in humans that mapped QTL for atherosclerosis and HDL-C to the syntenic region. Because the QTL interval is IBD in the parental strains, we propose next-generation sequencing as an effective tool for refining the linkage peak and identifying the underlying causal gene.
